| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2022 | Mouka A, Arkoun B, Moison P, Drévillon L, Jarray R, Brisset S, Mayeur A, Bouligand J, Boland-Auge A, Deleuze JF, Yates F, Lemonnier T, Callier P, Duffourd Y, Nitschke P, et al. iPSCs derived from infertile men carrying complex genetic abnormalities can generate primordial germ-like cells. Scientific Reports. 12: 14302. PMID 35995809 DOI: 10.1038/s41598-022-17337-2 | 0.43 | |||
| 2021 | Savatier P, David L, De Vos J, Yates F, Tajbakhsh S, Martinat C. [Chimeric embryos and pseudo-embryos: An alternative to human embryos for research]. Medecine Sciences : M/S. 37: 799-801. PMID 34491191 DOI: 10.1051/medsci/2021124 | 0.3 | |||
| 2020 | Nassor F, Jarray R, Biard DSF, Maïza A, Papy-Garcia D, Pavoni S, Deslys JP, Yates F. Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease. Frontiers in Cellular Neuroscience. 14: 14. PMID 32116560 DOI: 10.3389/Fncel.2020.00014 | 0.461 | |||
| 2019 | Roux GL, Jarray R, Guyot AC, Pavoni S, Costa N, Théodoro F, Nassor F, Pruvost A, Tournier N, Kiyan Y, Langer O, Yates F, Deslys JP, Mabondzo A. Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model. Scientific Reports. 9: 16310. PMID 31690750 DOI: 10.1038/S41598-019-52213-6 | 0.313 | |||
| 2018 | Pavoni S, Jarray R, Nassor F, Guyot AC, Cottin S, Rontard J, Mikol J, Mabondzo A, Deslys JP, Yates F. Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes. Plos One. 13: e0209150. PMID 30557391 DOI: 10.1371/Journal.Pone.0209150 | 0.313 | |||
| 2017 | Mouka A, Izard V, Tachdjian G, Brisset S, Yates F, Mayeur A, Drévillon L, Jarray R, Leboulch P, Maouche-Chrétien L, Tosca L. Induced pluripotent stem cell generation from a man carrying a complex chromosomal rearrangement as a genetic model for infertility studies. Scientific Reports. 7: 39760. PMID 28045072 DOI: 10.1038/Srep39760 | 0.465 | |||
| 2012 | Kobari L, Yates F, Oudrhiri N, Francina A, Kiger L, Mazurier C, Rouzbeh S, El-Nemer W, Hebert N, Giarratana MC, François S, Chapel A, Lapillonne H, Luton D, Bennaceur-Griscelli A, et al. Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica. 97: 1795-803. PMID 22733021 DOI: 10.3324/Haematol.2011.055566 | 0.58 | |||
| 2010 | Mitjavila-Garcia MT, Bonnet ML, Yates F, Haddad R, Oudrhiri N, Féraud O, Magniez A, Makhlouf M, Vallot C, Rougeulle C, Bennaceur-Griscelli A, Turhan AG. Partial reversal of the methylation pattern of the X-linked gene HUMARA during hematopoietic differentiation of human embryonic stem cells. Journal of Molecular Cell Biology. 2: 291-8. PMID 20823083 DOI: 10.1093/Jmcb/Mjq026 | 0.494 | |||
| 2010 | Oudrhiri N, Yates F, Feraud O, Gobbo E, Bas C, Luton D, Ceccaldi PF, Tachdjian G, Griscelli F, Turhan AG, Bennaceur-Griscelli A. MODELING GENETIC Diseases through Reprogramming of HUMAN Amniotic Liquid Derived CELLS Blood. 116: 4789-4789. DOI: 10.1182/Blood.V116.21.4789.4789 | 0.59 | |||
| 2009 | McKinney-Freeman SL, Naveiras O, Yates F, Loewer S, Philitas M, Curran M, Park PJ, Daley GQ. Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells. Blood. 114: 268-78. PMID 19420357 DOI: 10.1182/Blood-2008-12-193888 | 0.497 | |||
| 2008 | Chan EM, Yates F, Boyer LF, Schlaeger TM, Daley GQ. Enhanced plating efficiency of trypsin-adapted human embryonic stem cells is reversible and independent of trisomy 12/17. Cloning and Stem Cells. 10: 107-18. PMID 18241122 DOI: 10.1089/Clo.2007.0064 | 0.58 | |||
| 2007 | Lengerke C, McKinney-Freeman S, Naveiras O, Yates F, Wang Y, Bansal D, Daley GQ. The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells. Annals of the New York Academy of Sciences. 1106: 197-208. PMID 17303828 DOI: 10.1196/Annals.1392.006 | 0.656 | |||
| 2006 | Yates F, Daley GQ. Progress and prospects: gene transfer into embryonic stem cells. Gene Therapy. 13: 1431-9. PMID 17016468 DOI: 10.1038/Sj.Gt.3302854 | 0.627 | |||
| 2006 | Lagresle-Peyrou C, Yates F, Malassis-Séris M, Hue C, Morillon E, Garrigue A, Liu A, Hajdari P, Stockholm D, Danos O, Lemercier B, Gougeon ML, Rieux-Laucat F, de Villartay JP, Fischer A, et al. Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood. 107: 63-72. PMID 16174758 DOI: 10.1182/Blood-2005-05-2032 | 0.472 | |||
| 2005 | Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ. Embryonic stem cell-derived hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 19081-6. PMID 16357205 DOI: 10.1073/Pnas.0506127102 | 0.654 | |||
| 2005 | Lagresle-Peyrou C, Yates F, Malassis-Seris M, Hue C, Morillon E, Garrigue A, Liu A, Hajdari P, Stockholm D, Danos O, Lemercier B, Gougeon M, Rieux-laucat F, de Villartay J, Fischer A, et al. Retroviral Gene Therapy of RAG-1-/- Mice: Balance between Efficiency and Toxicity. Blood. 106: 460-460. DOI: 10.1182/blood.v106.11.460.460 | 0.438 | |||
| 2005 | Lengerke C, Wang Y, Yates F, Maouche-Chretien L, Daley GQ. BMP4 Favors Hematopoietic Differentiation from Murine Embryonic Stem Cells and Acts by Activation of the cdx-hox Pathway. Blood. 106: 3613-3613. DOI: 10.1182/Blood.V106.11.3613.3613 | 0.63 | |||
| 2004 | André-Schmutz I, Bonhomme D, Yates F, Malassis M, Selz F, Fischer A, Cavazzana-Calvo M. IL-7 effect on immunological reconstitution after HSCT depends on MHC incompatibility. British Journal of Haematology. 126: 844-51. PMID 15352989 DOI: 10.1111/J.1365-2141.2004.05134.X | 0.375 | |||
| 2004 | Wang Y, Yates F, Dikovskaia E, Ernst P, Davidson AJ, Zon LI, Daley GQ. Derivation of Hematopoietic Stem Cells from Embryonic Stem Cells. Blood. 104: 223-223. DOI: 10.1182/Blood.V104.11.223.223 | 0.663 | |||
| 2002 | Yates F, Malassis-Séris M, Stockholm D, Bouneaud C, Larousserie F, Noguiez-Hellin P, Danos O, Kohn DB, Fischer A, de Villartay JP, Cavazzana-Calvo M. Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood. 100: 3942-9. PMID 12393742 DOI: 10.1182/Blood-2002-03-0782 | 0.485 | |||
| 2002 | Cavazzana-Calvo M, Hacein-Bey S, Yates F, de Villartay JP, Le Deist F, Fischer A. Gene therapy of severe combined immunodeficiencies. The Journal of Gene Medicine. 3: 201-6. PMID 11437325 DOI: 10.1002/1521-2254(200105/06)3:3<201::Aid-Jgm195>3.0.Co;2-Z | 0.454 | |||
| Show low-probability matches. | |||||